sorafenib has been researched along with Brain Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Li, H; Wang, Z; Xu, X; You, W; Zhang, J; Zhou, D | 1 |
| Hill, KL; Lipson, AC; Sheehan, JM | 1 |
2 other study(ies) available for sorafenib and Brain Edema
| Article | Year |
|---|---|
Possible Role of Raf-1 Kinase in the Development of Cerebral Vasospasm and Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.
Topics: Animals; Basilar Artery; Blood-Brain Barrier; Brain Damage, Chronic; Brain Edema; Cyclooxygenase 2; Disease Models, Animal; Down-Regulation; Interleukin-1beta; Interleukin-6; Male; MAP Kinase Kinase Kinases; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase Kinases; Nerve Tissue Proteins; NF-kappa B; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sorafenib; Subarachnoid Hemorrhage; Vascular Endothelial Growth Factor A; Vasospasm, Intracranial | 2015 |
Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Brain; Brain Edema; Brain Neoplasms; Breast Neoplasms; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prospective Studies; Pyridines; Pyrroles; Seizures; Sorafenib; Sunitinib | 2009 |